SCIENCE IN THE NEWS DAILY
Vaccine Doubles Brain Cancer Survival Time
from the Guardian (UK)
A vaccine that more than doubles the survival time of patients with the most common and aggressive form of brain cancer has been developed by scientists.
Early results from clinical trials suggest patients who received the vaccine lived for nearly three years after being diagnosed with glioblastoma multiforme.
Patients given traditional anti-cancer treatment, including a combination of surgery, chemotherapy and radiotherapy, typically survived for a little more than a year following diagnosis. John Sampson, a neurosurgeon at Duke University's brain tumour centre in North Carolina, who led the trial, said: "We're more than doubling the survival time in this group, and we have some patients who are four, five or six years out from diagnosis, which is virtually unheard of in these people."
Read more ...
Connect With Us:
PODCAST & VIDEO: 3D Printing Replacement Body Parts
Regenerative medicine, a fledgling field with the aim of regrowing parts from a person’s own cells, is being amplified with 3D-printing technology, which can now use organic materials to create scaffolds that cells need to grow into their final forms. Richard Wysk, a professor of industrial and systems engineering at North Carolina State University, discusses the latest successes with this research, and the timeline for creating more complicated structures.
To view all multimedia content, click "Latest Multimedia."
Receive notification when new content is posted from the entire website, or choose from the customized feeds available.